359
Views
6
CrossRef citations to date
0
Altmetric
Review

Selective biliary cannulation techniques for endoscopic retrograde cholangiopancreatography procedures and prevention of post- endoscopic retrograde cholangiopancreatography pancreatitis

&
Pages 709-722 | Received 17 Oct 2015, Accepted 15 Jan 2016, Published online: 06 Feb 2016

References

  • Huibregtse K, Kimmey MB. Endoscopic retrograde cholangiopancreatography, endoscopic sphincterotomy and endoscopic biliary and pancreatic drainage. In: Yamada T, Alpers DH, Powell DW, editors. Textbook of Gastroenterology. 2nd ed. Philadelphia (PA): Lippincott; 1995. p. 2590–2617.
  • Freeman ML, Guda NM. ERCP cannulation: a review of reported techniques. Gastrointest Endosc. 2005;61:112–125.
  • Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc. 1991;37:383–393.
  • Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med. 1996;335:909–918.
  • Williams EJ, Taylor S, Fairclough P, et al. Risk factors for complication following ERCP; results of a large-scale, prospective multicenter study. Endoscopy. 2007;39:793–801.
  • Masci E, Toti G, Mariani A, et al., et al. Complications of diagnostic and therapeutic ERCP: a prospective multicenter study. Am J Gastroenterol. 2001;96:417–423.
  • Cheng C-L, Sherman S, Watkins JL, et al. Risk factors for post-ERCP pancreatitis: a prospective multicenter study. Am J Gastroenterol. 2006;101:139–147.
  • Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol. 2007;102:1781–1788.
  • Moss AC, Morris E, Leyden J, et al. Do the benefits of metal stents justify the costs? A systematic review and meta-analysis of trials comparing endoscopic stents for malignant biliary obstruction. Eur J Gastroenterol Hepatol. 2007;19:1119–1124.
  • Badalov N, Tenner S, Baillie J. The Prevention, recognition and treatment of post-ERCP pancreatitis. JOP. 2009;10:88–97.
  • Manes G. Prevention of ERCP-induced pancreatitis. Int Ther Gastrointest Endosc. 2010;27:311–318.
  • Shah TU, Liddle R, Branch MS, et al. Pilot study of aprepitant for prevention of post-ERCP pancreatitis in high risk patients: a phase II randomized, double blind placebo controlled trial. JOP. 2012;13:514–518.
  • Lella F, Bagnolo F, Colombo E, et al. A simple way of avoiding post-ERCP pancreatitis. Gastrointest Endosc. 2004;59:830–834.
  • Artifon EL, Sakai P, Cunha JE, et al. Guidewire cannulation reduces risk of post-ERCP pancreatitis and facilitates bile duct cannulation. Am J Gastroenterol. 2007;102:2147–2153.
  • Bailey AA, Bourke MJ, Williams SJ, et al. A prospective randomized trial of cannulation technique in ERCP: effects on technical success and post-ERCP pancreatitis. Endoscopy. 2008;40:296–301.
  • Katsinelos P, Paroutoglou G, Kountouras J, et al. A comparative study of standard ERCP catheter and hydrophilic guide wire in the selective cannulation of the common bile duct. Endoscopy. 2008;40(4):302–307.
  • Cennamo V, Fuccio L, Zagari RM, et al. Can a wire-guided cannulation technique increase bile duct cannulation rate and prevent post-ERCP pancreatitis? A meta-analysis of randomized controlled trials. Am J Gastroenterol. 2009;104:2343–2350.
  • Cheung J, Tsoi KK, Quan WL, et al. Guidewire versus conventional contrast cannulation of the common bile duct for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Gastrointest Endosc. 2009;70:1211–1219.
  • Tse F, Yuan Y, Moayyedi P, et al. Guide wire-assisted cannulation for the prevention of post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2013;45:605–618.
  • Kawakami H, Maguchi H, Mukai T, et al, A multicenter prospective randomized study of selective bile duct cannulation performed by multiple endoscopists: the BIDMEN study. Gastrointest Endosc. 2012;75:362–372.
  • Kobayashi G, Fujita N, Imaizumi K, et al. Wire-guided biliary cannulation technique does not reduce the risk of post-ERCP pancreatitis: multicenter randomized controlled trial. Dig Endosc. 2013;25:295–302.
  • Kawakami H, Maguchi H, Hayashi T, et al A prospective randomized controlled multicenter trial of duodenoscopes with 5 degrees and 15 degrees backward-oblique angle using wire-guided cannulation: effects on selective cannulation of the common bile duct in endoscopic retrograde cholangiopancreatography. J Gastroenterol. 2009;44:1140–1146.
  • Nambu T, Ukita T, Shigoka H, et al. Wire-guided selective cannulation of the bile duct with a sphincterotome: a prospective randomized comparative study with the standard method. Scand J Gastroenterol. 2011;46:109–115.
  • Halttunen J, Kylänpää L. A prospective randomized study of thin versus regular-sized guide wire in wire-guided cannulation. Surg Endosc. 2013;27:1662–1667.
  • Kitamura K, Yamamiya A, Ishii Y, et al. 0.025-inch vs 0.035-inch guide wires for wire-guided cannulation during endoscopic retrograde cholangiopancreatography: a randomized study. World J Gastroenterol. 2015;21:9182–9188.
  • Nakai Y, Isayama H, Sasahira N, et al. Risk factors for post-ERCP pancreatitis in wire-guided cannulation for therapeutic biliary ERCP. Gastrointest Endosc. 2015;81(1):119–126. [Epub 2014 Nov 5].
  • Dumonceau JM, Devière J, Cremer M. A new method of achieving deep cannulation of the common bile duct during endoscopic retrograde cholangiopancreatography. Endoscopy. 1998;30:S80.
  • Gotoh Y, Tamada K, Tomiyama T, et al. A new method for deep cannulation of the bile duct by straightening the pancreatic duct. Gastrointest Endosc. 2001;53:820–822.
  • Hayashi H, Maeda S, Hosokawa O, et al. A technique for selective cannulation of the common bile duct in endoscopic retrograde cholangiopancreatography. Insertion of guidewire into the pancreatic duct. Gastrointest Endosc. 2001;43:828–832.
  • Maeda S, Hayashi H, Hosokawa O, et al. Prospective randomized pilot trial of selective biliary cannulation using pancreatic guide-wire placement. Endoscopy. 2003;35:721–724.
  • Draganov P, Devonshire DA, Cunningham JT. A new technique to assist in difficult bile duct cannulation at the time of endoscopic retrograde cholangiopancreatography. JSLS. 2005;9:218–221.
  • Ito K, Fujita N, Noda Y, et al. Pancreatic guidewire placement for achieving selective biliary cannulation during endoscopic retrograde cholangiopancreatography. World J Gastroenterol. 2008;14:5595–5600.
  • Ito K, Fujita N, Noda Y, et al. Can pancreatic duct stenting prevent post-ERCP pancreatitis in patients who undergo pancreatic duct guidewire placement for achieving selective biliary cannulation? A prospective randomized controlled trial. J Gastroenterol. 2010;45:1183–1191.
  • Hisa T, Matsumoto R, Takamatsu M, et al. Impact of changing our cannulation method on the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis after pancreatic guidewire placement. World J Gastroenterol. 2011;17:5289–5294.
  • Xinopoulos D, Bassioukas SP, Kypreos D, et al. Pancreatic duct guidewire placement for biliary cannulation in a single-session therapeutic ERCP. World J Gastroenterol. 2011;17:1989–1995.
  • Gyökeres T, Duhl J, Varsányi M, et al. Double-guidewire placement for endoscopic pancreatobiliary procedures. Endoscopy. 2003;35:95–96.
  • de Tejada AH, Calleja JL, Diaz G, et al. Double-guidewire technique for difficult bile duct cannulation: a multicenter randomized, controlled trial. Gastrointest Endosc. 2009;70:700–709.
  • Grönroos JM, Vihervaara H, Gullichsen R, et al. Double-guidewire-assisted biliary cannulation: experiences from a single tertiary referral center. Surg Endosc. 2011;25:1599–1602.
  • Ito K, Horaguchi J, Fujita N, et al. Clinical usefulness of double-guidewire technique for difficult biliary cannulation in endoscopic retrograde cholangiopancreatography. Dig Endosc. 2014;26:442–449.
  • Tanaka R, Itoi T, Sofuni A, et al. Is the double-guidewire technique superior to the pancreatic duct guidewire technique in cases of pancreatic duct opacification? J Gastroenterol Hepatol. 2013;28:1787–1793.
  • Sasahira N, Kawakami H, Isayama H, et al. Early use of double-guidewire technique to facilitate selective bile duct cannulation: the multicenter randomized controlled EDUCATION trial. Endoscopy. 2015;47:421–429.
  • Udd M, Kylänpää L, Halttunen J. Management of difficult bile duct cannulation in ERCP. World J Gastrointest Endosc. 2010;2:97–103.
  • Siegel JH. Precut papillotomy: a method to improve success of ERCP and papillotomy. Endoscopy. 1980;12:130–133.
  • Masci E, Mariani A, Curioni S, et al. Risk factors for pancreatitis following endoscopic retrograde cholangiopancreatography: a meta-analysis. Endoscopy. 2003;35:830–834.
  • Mavrogiannis C, Liatsos C, Romanos A, et al. Needle-knife fistulotomy versus needle-knife precut papillotomy for the treatment of common bile duct stones. Gastrointest Endosc. 1999;50:334–339.
  • Goff JS. Common bile duct pre-cut sphincterotomy: transpancreatic sphincter approach. Gastrointest Endosc. 1995;41:502–505.
  • Wang P, Zhang W, Liu F, et al. Success and complication rates of two precut techniques, transpancreatic sphincterotomy and needle-knife sphincterotomy for bile duct cannulation. J Gastrointest Surg. 2010;14:697–704.
  • Lee YJ, Park YK, Lee MJ, et al. Different strategies for transpancreatic septotomy and needle knife infundibulotomy due to the presence of unintended pancreatic cannulation in difficult biliary cannulation. Gut Liver. 2015;9:534–539.
  • Katsinelos P, Gkagkalis S, Chatzimavroudis G, et al. Comparison of three types of precut technique to achieve common bile duct cannulation: a retrospective analysis of 274 cases. Dig Dis Sci. 2012;57:3286–3292.
  • Cha SW, Leung WD, Lehman GA, et al. Does leaving a main pancreatic duct stent in place reduce the incidence of precut biliary sphincterotomy-associated pancreatitis? A randomized, prospective study. Gastrointest Endosc. 2013;77:209–216.
  • Parlak E, Cicek B, Disibeyaz S, et al. Early decision for precut sphincterotomy: is it a risky preference? Dig Dis Sci. 2007;52:845–851.
  • Manes G, Di Giorgio P, Repici A, et al. An analysis of the factors associated with the development of complications in patients undergoing precut sphincterotomy: a prospective, controlled, randomized, multicenter study. Am J Gastroenterol. 2009;104:2412–2417.
  • Cennamo V, Fuccio L, Zagari RM, et al. Can early precut implementation reduce endoscopic retrograde cholangiopancreatography-related complication risk? Meta-analysis of randomized controlled trials. Endoscopy. 2010;42:381–388.
  • Lobo DN, Balfour TW, Iftikhar SY, et al. Periampullary diverticula and pancreaticobiliary disease. Br J Surg. 1999;86:588–597.
  • Løtveit T, Skar V, Osnes, M. Juxtapapillary duodenal diverticula. Endoscopy. 1988;20:175–178.
  • Tyagi P, Sharma P, Sharma BC, et al. Periampullary diverticula and technical success of endoscopic retrograde cholangiopancreatography. Surg Endosc. 2009;23:1342–1345.
  • Fujita N, Noda Y, Kobayashi G, et al. ERCP for intradiverticular papilla: two-devices-in-one-channel method. Endoscopic retrograde cholangiopancreatography. Gastrointest Endosc. 1998;48:517–520.
  • Chan C, Brennan FN, Raftopoulas SC, et al. Loop tip wire guided cannulation is a safe and effective technique even when performed by trainee endoscopists. J Gastroenterol Hepatol. 2010;25:A66.
  • Chun SY, Kim JH, Moon SH, et al. The loop-tip wire for selective cannulation during ERCP in Patients with Billroth II Anastomosis: A preliminary feasibility study. Hepatogastroenterology. 2014;61:897–901.
  • Omuta S, Maetani I, Shigoka S, et al. Newly designed J-shaped tip guidewire: a preliminary feasibility study in wire-guided cannulation. World J Gastroenterol. 2013;19:4531–4536.
  • Tsuchiya T, Itoi T, Maetani I, et al. Effectiveness of the J-Tip guidewire for selective biliary cannulation compared to conventional guidewires (The JANGLE Study). Dig Dis Sci. 2015;60:2502–2508.
  • Mallery S, Matlock J, Freeman ML. EUS-guided rendezvous drainage of obstructed biliary and pancreatic ducts: Report of 6 cases. Gastrointest Endosc. 2004;59:100–107.
  • Kahaleh M, Wang P, Shami VM, et al. EUS-guided transhepatic cholangiography: report of 6 cases. Gastrointest Endosc. 2005;61:307–313.
  • Lai R, Freeman ML. Endoscopic ultrasound-guided bile duct access for rendezvous ERCP drainage in the setting of intradiverticular papilla. Endoscopy. 2005;37:487–489.
  • Kim YS, Gupta K, Mallery S, et al. Endoscopic ultrasound rendezvous for bile duct access using a transduodenal approach: cumulative experience at a single center. A case series. Endoscopy. 2010;42:496–502.
  • Dhir V, Bhandari S, Bapat M, et al. Comparison of EUS-guided rendezvous and precut papillotomy techniques for biliary access (with videos). Gastrointest Endosc. 2012;75:354–359.
  • Kawakubo K, Isayama H, Sasahira N, et al. Clinical utility of an endoscopic ultrasound-guided rendezvous technique via various approach routes. Surg Endosc. 2013;27:3437–3443.
  • Khashab MA, Valeshabad AK, Modayil R, et al. EUS-guided biliary drainage by using a standardized approach for malignant biliary obstruction: rendezvous versus direct transluminal techniques (with videos). Gastrointest Endosc. 2013;78:734–741.
  • Park DH, Jeong SU, Lee BU, et al. Prospective evaluation of a treatment algorithm with enhanced guidewire manipulation protocol for EUS-guided biliary drainage after failed ERCP (with video). Gastrointest Endosc. 2013;78:91–101.
  • Iwashita T, Doi S, Yasuda I. Endoscopic ultrasound-guided biliary drainage: a review. Clin J Gastroenterol. 2014;7:94–102.
  • Iwashita T, Yasuda I, Mukai T, et al. EUS-guided rendezvous for difficult biliary cannulation using a standardized algorithm: a multicenter prospective pilot study (with videos). Gastrointest Endosc. 2015 Jun 16. pii: S0016-5107(15)02403-7. doi:10.1016/j.gie.2015.04.043. [Epub ahead of print].
  • Donnellan F, Byrne MF. Prevention of post-ERCP pancreatitis. Gastroenterol Res Pract. 2012;2012:12.
  • Bhasin DK, Rana SS, Nadkarni N. Protocol-based management strategy for post-endoscopic retrograde cholangiopancreatography pancreatitis: can it make a difference? J Gastroenterol Hepatol. 2008;23:344–347.
  • Chen YK, Foliente RL, Santoro MJ, et al. Endoscopic sphincterotomy induced pancreatitis: increased risk associated with nondilated bile ducts and sphincter of Oddi dysfunction. Am J Gastroenterol. 1994;89:327–333.
  • Dickinson RJ, Davies S. Post-ERCP pancreatitis and hyperamylasaemia: the role of operative and patient factors. Eur J Gastroenterol Hepatol. 1998;10:423–428.
  • Loperfido S, Angelini G, Benedetti G, et al. Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study. Gastrointest Endosc. 1998;48:1–10.
  • Freeman ML, DiSario JA, Nelson DB, et al. Risk factors for post-ERCP pancreatitis: a prospective, multicenter study. Gastrointest Endosc. 2001;54:425–434.
  • Dumonceau JM, Andriulli A, Deviere J, et al. European Society of Gastrointestinal Endoscopy (ESGE) guideline: prophylaxis of post-ERCP pancreatitis. Endoscopy. 2010;42:503–515.
  • Moffatt DC, Coté GA, Avula H, et al. Risk factors for ERCP related complications in patients with pancreas divisum: a retrospective study. Gastrointest Endosc. 2011;73:963–970.
  • Gottlieb K, Sherman S. ERCP and biliary endoscopic sphincterotomy-induced pancreatitis. Gastrointest Endosc Clin N Am. 1998;8:87–114.
  • Freeman ML. Adverse outcomes of endoscopic retrograde cholangiopancreatography. Rev Gastroenterol Disord. 2002;2:147–168.
  • Sofuni A, Maguchi H, Mukai T, et al. Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients. Clin Gastroenterol Hepatol. 2011;9:851–858.
  • Tarnasky PR, Palesch YY, Cunningham JT, et al. Pancreatic stenting prevents pancreatitis after biliary sphincterotomy in patients with sphincter of Oddi dysfunction. Gastroenterology. 1998;115:1518–1524.
  • Aizawa T, Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc. 2001;54:209–213.
  • Fogel EL, Eversman D, Jamidar P, et al. Sphincter of Oddi dysfunction: pancreaticobiliary sphincterotomy with pancreatic stent placement has a lower rate of pancreatitis than biliary sphincterotomy alone. Endoscopy. 2002;34:280–285.
  • Fazel A, Quadri A, Catalano MF, et al. Does a pancreatic duct stent prevent post-ERCP pancreatitis? A prospective randomized study. Gastrointest Endosc. 2003;57:291–294.
  • Freeman ML, Overby C, Qi D. Pancreatic stent insertion: Consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc. 2004;59:8–14.
  • Harewood GC, Pochron NL, Gostout CJ. Prospective, randomized, controlled trial of prophylactic pancreatic stent placement for endoscopic snare excision of the duodenal ampulla. Gastrointest Endosc. 2005;62:367–370.
  • Tsuchiya T, Itoi T, Sofuni A, et al. Temporary pancreatic stent to prevent post endoscopic retrograde cholangiopancreatography pancreatitis: A preliminary, single-center, randomized controlled trial. J Hepatobiliary Pancreat Surg. 2007;14:302–307.
  • Sofuni A, Maguchi H, Itoi T, et al. Prophylaxis of postendoscopic retrograde cholangiopancreatography pancreatitis by an endoscopic pancreatic spontaneous dislodgement stent. Clin Gastroenterol Hepatol. 2007;5:1339–1346.
  • Smithline A, Silverman W, Rogers D, et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc. 1993;39:652–657.
  • Patel R, Transky P, Hennessy WS, et al. Does stenting after pancreatic sphincterotomy reduce post-ERCP pancreatitis with prior biliary sphincterotomy? Gastrointest Endosc. 1999;49:AB80.
  • Pan X-P, Dang T, Meng X-M, et al. Clinical study on the prevention of post-ERCP pancreatitis by pancreatic duct stenting. Cell Biochem Biophys. 2011;61:473–479.
  • Kawaguchi Y, Ogawa M, Omata F, et al. Randomized controlled trial of pancreatic stenting to prevent pancreatitis after endoscopic retrograde cholangiopancreatography. World J Gastroenterol. 2012;18:1635–1641.
  • Lee TH, Moon JH, Choi HJ, et al. Prophylactic temporary 3F pancreatic duct stent to prevent post-ERCP pancreatitis in patients with a difficult biliary cannulation: a multicenter, prospective, randomized study. Gastrointest Endosc. 2012;76:578–585.
  • Mazaki T, Masuda H, Takayama T. Prophylactic pancreatic stent placement and post-ERCP pancreatitis: a systematic review and meta-analysis. Endoscopy. 2010;42:842–853.
  • Choudhary A, Bechtold ML, Arif M, et al. Pancreatic stents for prophylaxis against post-ERCP pancreatitis: a meta-analysis and systematic review. Gastrointest Endosc. 2011;73:275–282.
  • Shi -Q-Q, Ning X-Y, Zhan -L-L, et al. Placement of prophylactic pancreatic stents to prevent post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients: a meta-analysis. World J Gastroenterol. 2014;20:7040–7048.
  • Rashdan A, Fogel EL, Mchenry L Jr, et al. Improved stent characteristics for prophylaxis of post-ERCP pancreatitis. Clin Gastroenterol Hepatol. 2004;2:322–329.
  • Fehmi SMA, Schoenfeld PS, Scheiman JM, et al. 5 Fr prophylactic pancreatic stents are easier to place and require fewer guide wires than 3 Fr stents. Gastrointest Endosc. 2008;67:AB328–329.
  • Chahal P, Tarnasky P, Petersen B, et al. Short 5Fr vs long 3Fr pancreatic stents in patients at risk for post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol. 2009;7:834–839.
  • Das A, Singh P, Sivak MV, et al. Pancreatic-stent placement for prevention of post-ERCP pancreatitis: a cost-effectiveness analysis. Gastrointest Endosc. 2007;65:960–968.
  • Gross V, Leser HG, Heinisch A, et al. Inflammatory mediators and cytokines—new aspects of the pathophysiology and assessment of severity of acute pancreatitis? Hepatogastroenterol. 1993;l40:522–530.
  • Bhatia M, Brady M, Shokuhi S, et al. Inflammatory mediators in acute pancreatitis. J Pathol. 2000;190:117–125.
  • Karne S, Gorelick FS. Etiopathogenesis of acute pancreatitis. Surg Clin North Am. 1999;79:699–710.
  • Mäkelä A, Kuusi T, Schröder T. Inhibition of serum phospholipase-A2 in acute pancreatitis by pharmacological agents in vitro. Scand J Clin Lab Invest. 1997;57:401–407.
  • Murray B, Carter R, Imrie C, et al. Diclofenac reduces the incidence of acute pancreatitis after endoscopic retrograde cholangiopancreatography. Gastroenterology. 2003;124:1786–1791.
  • Cheon YK, Cho KB, Watkins JL, et al. Efficacy of diclofenac in the prevention of post-ERCP pancreatitis in predominantly high risk patients: a randomized double-blind prospective trial. Gastrointest Endosc. 2007;66:1126–1132.
  • Sotoudehmanesh R, Khatibian M, Kolahdoozan S, et al. Indomethacin may reduce the incidence and severity of acute pancreatitis after ERCP. Am J Gastroenterol. 2007;102:978–983.
  • Khoshbaten M, Khorram H, Madad L, et al. Role of diclofenac in reducing post-endoscopic retrograde cholangiopancreatography pancreatitis. J Gastroenterol Hepatol. 2008;23:e11–16.
  • Elmunzer BJ, Scheiman JM, Lehman GA, et al. A randomized trial of rectal indomethacin to prevent post-ERCP pancreatitis. N Engl J Med. 2012;366:1414–1422.
  • Otsuka T, Kawazoe S, Nakashita S, et al. Low-dose rectal diclofenac for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis: a randomized controlled trial. J Gastroenterol. 2012;47:912–917.
  • Montano Loza A, Rodriguez Lomeli X, Garcia Correa JE, et al. Effect of the administration of rectal indomethacin on amylase serum levels after endoscopic retrograde cholangiopancreatography, and its impact on the development of secondary pancreatitis episodes. Rev Esp Enferm Dig. 2007;99:330–336.
  • Döbrönte Z, Toldy E, Márk L, et al. Effects of rectal indomethacin in the prevention of post-ERCP acute pancreatitis. Orv Hetil. 2012;153:990–996.
  • Li X, Tao L-P, Wang C-H. Effectiveness of nonsteroidal anti-inflammatory drugs in prevention of post-ERCP pancreatitis: a meta-analysis. World J Gastroenterol. 2014;20(34):12322–12329.
  • Elmunzer BJ, Waljee AK, Elta GH, et al. A meta-analysis of rectal NSAIDs in the prevention of post-ERCP pancreatitis. Gut. 2008;57:1262–1267.
  • Dai H-F, Wang X-W, Zhao K. Role of nonsteroidal anti-inflammatory drugs in the prevention of post-ERCP pancreatitis: a meta-analysis. Hepatobiliary Pancreat Dis Int. 2009;8:11–16.
  • Ding X, Chen M, Huang S, et al. Nonsteroidal anti-inflammatory drugs for prevention of post-ERCP pancreatitis: a meta-analysis. Gastrointest Endosc. 2012;76:1152–1159.
  • Zheng M-H, Xia HH, Chen Y-P. Rectal administration of NSAIDs in the prevention of post-ERCP pancreatitis: a complementary meta-analysis. Gut. 2008;57:1632–1633.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.